Top compounds associated with response to HTR2C


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.0035 0.9
mRNA GSK-650394 GDSC1000 pan-cancer AAC -0.0035 0.9
mRNA cediranib CTRPv2 pan-cancer AAC -0.0049 0.9
mRNA FR-180204 GDSC1000 pan-cancer AAC -0.003 0.9
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.003 0.9
mRNA BI-2536 FIMM pan-cancer AAC -0.011 0.9
mRNA MK-2206 GDSC1000 pan-cancer AAC 0.003 0.9
mRNA nintedanib CTRPv2 pan-cancer AAC 0.003 0.9
mRNA KU-60019 CTRPv2 pan-cancer AAC -0.0028 0.9
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.0028 0.9
Download CSV